Journal
BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 9, Issue 4, Pages 347-353Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elq014
Keywords
RB1; imprinting; DNA methylation
Funding
- Deutsche Forschungsgemeinschaft [KFO 109 Lo530/5-4]
- Bundesministerium fur Bildung und Forschung Network Imprinting diseases [01GM0882-886]
Ask authors/readers for more resources
Recent data have revealed that the paradigmatic tumour suppressor gene RB1 on chromosome 13 is preferentially expressed from the maternal allele. Imprinted expression of RB1 is linked to a differentially methylated CpG island in intron 2 of this gene (CpG 85). On the paternal chromosome, CpG 85 is unmethylated and acts as a weak promoter of an alternative RB1 transcript. Paternal mRNA levels are probably reduced as the result of transcriptional interference of the regular promoter and the alternative promoter on this chromosome. CpG 85 is part of a truncated processed pseudogene (KIAA0649P) that integrated into the RB1 gene prior to the speciation of extant primates. It is plausible that differential penetrance and variation of age at diagnosis, which have been observed in patients with hereditary and non-hereditary retinoblastoma, respectively, are a consequence of imprinted expression of the RB1 gene. Interestingly, RB1 is imprinted in the same direction as CDKN1C, which operates upstream of RB1. The imprinting of two components of the same pathway indicates that there has been strong evolutionary selection for maternal inhibition of cell proliferation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available